These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2004437)

  • 1. Further insights into the pathophysiology of hyperapobetalipoproteinemia: role of basic proteins I, II, III.
    Kwiterovich PO; Motevalli M; Miller M; Bachorik PS; Kafonek SD; Chatterjee S; Beaty T; Virgil D
    Clin Chem; 1991 Mar; 37(3):317-26. PubMed ID: 2004437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal protein tyrosine phosphorylation in fibroblasts from hyperapobetalipoproteinemia subjects.
    Motevalli M; Goldschmidt-Clermont PJ; Virgil D; Kwiterovich PO
    J Biol Chem; 1997 Sep; 272(39):24703-9. PubMed ID: 9305942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acylation-stimulatory activity in hyperapobetalipoproteinemic fibroblasts: enhanced cholesterol esterification with another serum basic protein, BP II.
    Kwiterovich P; Motevalli M; Miller M
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8980-4. PubMed ID: 2247473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic deficiency of acylation stimulating protein (ASP(C3ades-Arg)) does not cause hyperapobetalipoproteinemia in mice.
    Wetsel RA; Kildsgaard J; Zsigmond E; Liao W; Chan L
    J Biol Chem; 1999 Jul; 274(27):19429-33. PubMed ID: 10383458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of genistein on the stimulation of cholesterol production by basic protein II in normal and hyperapoB fibroblasts.
    Kwiterovich PO; Motevalli M
    Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):57-64. PubMed ID: 9445257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HyperapoB: a pleiotropic phenotype characterized by dense low-density lipoproteins and associated with coronary artery disease.
    Kwiterovich PO
    Clin Chem; 1988; 34(8B):B71-7. PubMed ID: 3042202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein.
    Cianflone KM; Maslowska MH; Sniderman AD
    J Clin Invest; 1990 Mar; 85(3):722-30. PubMed ID: 2312723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of three serum basic proteins on the mass of lipids in normal and hyperapoB fibroblasts.
    Kwiterovich PO; Motevalli M; Miller M
    Arterioscler Thromb; 1994 Jan; 14(1):1-7. PubMed ID: 8274464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical evaluation of the putative role of C3adesArg (ASP) in lipid metabolism and hyperapobetalipoproteinemia.
    Kildsgaard J; Zsigmond E; Chan L; Wetsel RA
    Mol Immunol; 1999; 36(13-14):869-76. PubMed ID: 10698341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma acylation stimulating protein (ASP) as a predictor of impaired cellular biological response to ASP in patients with hyperapoB.
    Zhang XJ; Cianflone K; Genest J; Sniderman AD
    Eur J Clin Invest; 1998 Sep; 28(9):730-9. PubMed ID: 9767372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adipsin system--acylation-stimulation protein (ASP) and hyperapo-B].
    Rato Q; Cianflone K; Sniderman A
    Rev Port Cardiol; 1996 May; 15(5):433-8, 366. PubMed ID: 8763517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiologic heterogeneity of hyperapobetalipoproteinemia (hyperapoB). Results from segregation analysis in families with premature coronary artery disease.
    Juo SH; Beaty TH; Kwiterovich PO
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2729-36. PubMed ID: 9409249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a plasma protein fraction on lipid synthesis in cultured skin fibroblasts from normals and patients with hyperapobetalipoproteinemia.
    Cianflone K; Rodriguez MA; Walsh M; Vu H; Sniderman AD
    Clin Invest Med; 1988 Apr; 11(2):99-107. PubMed ID: 3396258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenetic role of impaired fatty acid trapping by adipocytes in generating the pleiotropic features of hyperapoB.
    Sniderman AD; Cianflone K; Frayn K
    Diabetologia; 1997 Jul; 40 Suppl 2():S152-4. PubMed ID: 9248727
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of protein tyrosine kinase alters the effect of serum basic protein I on triacylglycerols and cholesterol differently in normal and hyperapoB fibroblasts.
    Kwiterovich PO; Motevalli M
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1195-203. PubMed ID: 7627714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men (aged < or = 50 years) and women (< or = 60 years) with coronary artery disease.
    Kwiterovich PO; Coresh J; Bachorik PS
    Am J Cardiol; 1993 Mar; 71(8):631-9. PubMed ID: 8447257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric hyperlipoproteinemia: the phenotypic expression of hyperapobetalipoproteinemia in young probands and their parents.
    Kwiterovich P; Beaty T; Bachorik P; Chen J; Franklin F; Georgopoulos L; Sniderman A
    Prog Clin Biol Res; 1988; 255():89-105. PubMed ID: 3340649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic disruptions in the adipocyte-hepatocyte fatty acid axis as causes of HyperapoB.
    Sniderman AD; Cianflone K
    Int J Obes Relat Metab Disord; 1995 May; 19 Suppl 1():S27-33. PubMed ID: 7550535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ApoE phenotype influences plasma ASP in hyperapoB subjects.
    Cianflone K; Phélis S; Davignon J; Gilfix BM
    Atherosclerosis; 2003 Oct; 170(2):285-91. PubMed ID: 14612209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hyperapo B LDL on cholesterol esterification in THP-1 macrophages.
    Kafonek SD; Raikhel I; Bachorik PS; Kwiterovich PO
    Atherosclerosis; 1993 Aug; 102(1):23-36. PubMed ID: 8257450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.